Savithri Ramurthy

ORCID

Publication Activity (10 Years)

Years Active: 2017-2019
Publications (10 Years): 4

Top Venues

Journal of medicinal chemistry

ACS infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaolei Ma, Ramadevi Prathapam, Charles Wartchow, Barbara Chie-Leon, Chi-Min Ho, Javier De Vicente, Wooseok Han, Min Li, Yipin Lu, Savithri Ramurthy, Steven Shia, Micah Steffek, Tsuyoshi Uehara
Structural and Biological Basis of Small Molecule Inhibition of Escherichia coli LpxD Acyltransferase Essential for Lipopolysaccharide Biosynthesis. ACS infectious diseases 6 (6) (2019)
Savithri Ramurthy, Benjamin R Taft, Robert J Aversa, Paul A Barsanti, Matthew T Burger, Yan Lou, Gisele A Nishiguchi, Alice Rico, Lina Setti, Aaron Smith, Sharadha Subramanian, Victoriano Tamez, Huw Tanner, Lifeng Wan, Cheng Hu, Brent A Appleton, Mulugeta Mamo, Laura Tandeske, John E Tellew, Shenlin Huang, Qin Yue, Apurva Chaudhary, Hung Tian, Raman Iyer, A Quamrul Hassan, Lesley A Mathews Griner, Laura R La Bonte, Vesselina G Cooke, Anne Van Abbema, Hanne Merritt, Kalyani Gampa, Fei Feng, Jing Yuan, Yuji Mishina, Yingyun Wang, Jacob R Haling, Sepideh Vaziri, Mohammad Hekmat-Nejad, Valery Polyakov, Richard Zang, Vijay Sethuraman, Payman Amiri, Mallika Singh, William R Sellers, Emma Lees, Wenlin Shao, Michael P Dillon, Darrin D Stuart
Design and Discovery of N-(3-(2-(2-Hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the Clinic. Journal of medicinal chemistry 63 (5) (2019)
Allan S Wagman, Rustum S Boyce, Sean P Brown, Eric Fang, Dane Goff, Johanna M Jansen, Vincent P Le, Barry H Levine, Simon C Ng, Zhi-Jie Ni, John M Nuss, Keith B Pfister, Savithri Ramurthy, Paul A Renhowe, David B Ring, Wei Shu, Sharadha Subramanian, Xiaohui A Zhou, Cynthia M Shafer, Stephen D Harrison, Kirk W Johnson, Dirksen E Bussiere
Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3. Journal of medicinal chemistry 60 (20) (2017)
Gisele A Nishiguchi, Alice Rico, Huw Tanner, Robert J Aversa, Benjamin R Taft, Sharadha Subramanian, Lina Setti, Matthew T Burger, Lifeng Wan, Victoriano Tamez, Aaron Smith, Yan Lou, Paul A Barsanti, Brent A Appleton, Mulugeta Mamo, Laura Tandeske, Ina Dix, John E Tellew, Shenlin Huang, Lesley A Mathews Griner, Vesselina G Cooke, Anne Van Abbema, Hanne Merritt, Sylvia Ma, Kalyani Gampa, Fei Feng, Jing Yuan, Yingyun Wang, Jacob R Haling, Sepideh Vaziri, Mohammad Hekmat-Nejad, Johanna M Jansen, Valery Polyakov, Richard Zang, Vijay Sethuraman, Payman Amiri, Mallika Singh, Emma Lees, Wenlin Shao, Darrin D Stuart, Michael P Dillon, Savithri Ramurthy
Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers. Journal of medicinal chemistry 60 (12) (2017)

Savithri Ramurthy.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Savithri Ramurthy